Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    MTE07 - Treatment of Elderly Patients with Lung Cancer (Ticketed Session)

    • Type: Meet the Expert Session (Ticketed Session)
    • Track: Advanced NSCLC
    • Presentations: 1
    • Coordinates: 12/05/2016, 07:30 - 08:30, Lehar 1-2
  • +

    P1.03 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Radiology/Staging/Screening
    • Presentations: 84
    • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P1.03-019 - Imaging of Anti-PD1 Therapy Response in Advanced Non-Small Lung Cancer

      14:30 - 14:30  |  Author(s): S.I. Katz

      • Abstract

      Loading...

  • +

    OA08 - Targeted Therapies in Brain Metastases

    • Type: Oral Session
    • Track: Advanced NSCLC
    • Presentations: 8
    • Moderators:D. Ball
    • Coordinates: 12/05/2016, 16:00 - 17:30, Schubert 1
  • +

    MA08 - Treatment Monitoring in Advanced NSCLC

    • Type: Mini Oral Session
    • Track: Advanced NSCLC
    • Presentations: 12
    • Moderators:R. Perez-Soler
    • Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 3-4
    • +

      MA08.01 - A Highly Sensitive Next-Generation Sequencing Platform for Detection of NSCLC EGFR T790M Mutation in Urine and Plasma

      11:00 - 11:06  |  Author(s): H. Wakelee

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA09 - Immunotherapy Combinations

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:M. Sebastian
    • Coordinates: 12/06/2016, 14:20 - 15:50, Strauss 2
    • +

      MA09.02 - Pembrolizumab + Carboplatin and Pemetrexed as 1st-Line Therapy for Advanced Non–Small Cell Lung Cancer: KEYNOTE-021 Cohort G

      14:26 - 14:32  |  Author(s): C. Langer

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.03a - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 72
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.03a-039 - ABOUND.70+: Interim Quality of Life (QoL) Results of nab-Paclitaxel/Carboplatin Treatment of Elderly Patients With NSCLC

      14:30 - 14:30  |  Author(s): J. Weiss

      • Abstract

      Loading...

    • +

      P2.03a-046 - Safety and Efficacy Results From ABOUND.70+: nab-Paclitaxel/Carboplatin in Elderly Patients With Advanced NSCLC

      14:30 - 14:30  |  Author(s): C. Langer

      • Abstract

      Loading...

  • +

    SH06 - WCLC 2016 Scientific Highlights - Radiotherpay, Palliative Care, Regional Aspects

    • Type: Scientific Highlights
    • Track: Radiotherapy
    • Presentations: 3
    • Coordinates: 12/07/2016, 07:30 - 08:30, Hall C7
  • +

    MA16 - Novel Strategies in Targeted Therapy

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:G. Purkalne
    • Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
  • +

    P3.02a - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 37
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02a-013 - Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Central Assessment and Updates from ALTA, a Pivotal Randomized Phase 2 Trial

      14:30 - 14:30  |  Author(s): D..R. Camidge

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.02c - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 103
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02c-028 - Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)

      14:30 - 14:30  |  Author(s): S.J. Bagley

      • Abstract

      Loading...

    • +

      P3.02c-029 - Immune-Related Adverse Events and Their Effect on Outcomes in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab

      14:30 - 14:30  |  Author(s): S. Kothari

      • Abstract

      Loading...

    • +

      P3.02c-069 - Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

      14:30 - 14:30  |  Author(s): S.J. Bagley

      • Abstract

      Loading...